Diagnosis of cases of early recurrence after resection of pancreatic cancer
Not Applicable
Recruiting
- Conditions
- pancreatic ductal adenocarcinoma
- Registration Number
- JPRN-UMIN000045116
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
None in particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of miRs associated with early recurrence
- Secondary Outcome Measures
Name Time Method Relationship between candidate miRs and prognosis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of exosome analysis identify high-risk early recurrence in pancreatic ductal adenocinoma post-surgery?
How does temporal exosome profiling compare to standard imaging techniques in predicting pancreatic cancer recurrence after resection?
Which specific biomarkers in exosome analysis correlate with early recurrence risk in pancreatic ductal adenocarcinoma patients?
What adverse events are associated with exosome-based diagnostic methods in pancreatic cancer management?
Are there combination approaches involving exosome analysis and existing therapies for postoperative pancreatic ductal adenocarcinoma recurrence prevention?